[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352250-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352250-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","zc3h15-regulates-the-ubiquitination-of-pten-via-recruitment-of-trim56-and-promotes-malignant-progression-of-non-small-cell-lung-cancer","ZC3H15 regulates the ubiquitination of PTEN via recruitment of TRIM56 and promotes malignant progression of non-small cell lung cancer","","Non-small cell lung cancer (NSCLC) remains a major cause of cancer mortality, with limited survival and frequent metastasis at diagnosis. This study integrates transcriptome datasets from GEO and TCGA to identify ZC3H15 as a key differentially expressed gene elevated in NSCLC, linked to tumor size, TNM stage, lymph node metastasis, and poor prognosis. Mechanistically, ZC3H15 binds PTEN through its DFRP domain and recruits TRIM56 to enhance PTEN ubiquitination, lowering PTEN expression while activating AKT-mTOR signaling and increasing cisplatin resistance. Results support ZC3H15 as a therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/zc3h15-regulates-the-ubiquitination-of-pten-via-recruitment-of-trim56-and-promotes-malignant-progression-of-non-small-cell-lung-cancer/352250/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/zc3h15-regulates-the-ubiquitination-of-pten-via-recruitment-of-trim56-and-promotes-malignant-progression-of-non-small-cell-lung-cancer/352250.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How was ZC3H15 identified as relevant to NSCLC?","Question",{"text":63,"@type":64},"The study integrated transcriptome data from GEO and TCGA and used bioinformatics to screen key differentially expressed genes, identifying ZC3H15 as significantly increased in NSCLC tissue.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What molecular mechanism links ZC3H15 to PTEN and tumor progression?",{"text":68,"@type":64},"ZC3H15 binds PTEN via its DFRP structural domain and recruits the E3 ligase TRIM56, promoting PTEN ubiquitination and reducing PTEN expression.",{"name":70,"@type":61,"acceptedAnswer":71},"How does ZC3H15 affect chemotherapy sensitivity and signaling pathways?",{"text":72,"@type":64},"Overexpression of ZC3H15 activates AKT-mTOR signaling, increases NSCLC proliferation, migration, and invasion, and enhances resistance to cisplatin.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352250,1790806919,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nZC3H15 regulates the ubiquitination of PTEN via recruitment of TRIM56 and promotes malignant progression of non-small cell lung cancer  \nPeihong Wu1, Peifeng Yao2, Mingfang Zhao 1 ✉ and Ming Cheng 3 ✉  \n© The Author(s) 2025  \n\n|  |  |  |\n| --- | --- | --- |\n|  | Lung cancer is one of the most common cancers worldwide and the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer cases and has a 5-year survival rate of ~19% . Since more than half of NSCLC patients present with metastatic disease at the time of diagnosis, early diagnosis is crucial for providing patients with the most effective treatment strategy. This study integrated transcriptome data between cancer and adjacent tissues from GEO and TCGA databases through bioinformatics analysis, and screened zinc ﬁnger CCCH-type containing 15 (ZC3H15) as a key differentially expressed gene in NSCLC. ZC3H15 expression levels were found to be signiﬁcantly higher in NSCLC tissue than normal tissue and correlated with tumor size, TNM stage, lymph node metastasis and poor prognosis of patients. Overexpression of ZC3H15 promoted the proliferation, migration and invasion of NSCLC cells through activation of the AKT-mTOR signaling pathway. To elucidate the underlying molecular mechanism, we determined that ZC3H15 could bind to PTEN through its DFRP structural domain and recruited the E3 ligase TRIM56 to promote PTEN ubiquitination. In addition, overexpression of ZC3H15 increased the resistance of NSCLC cells to cisplatin. Therefore, ZC3H15 promotes the malignant phenotype of NSCLC through recruitment of TRIM56 to ubiquitinate PTEN, decreasing its expression and driving increased AKT-mTOR signaling pathway and cisplatin resistance. These ﬁndings provide a scientiﬁc basis for the development of targeted therapies against ZC3H15, which may lead to new |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | therapeutic strategies for NSCLC patients. |  |\n|  | Cell Death and Disease (2026)17:17; [https://doi.org/10.1038/s41419-025-08138-2](https://doi.org/10.1038/s41419-025-08138-2) |  |\n|  |  |  |\n\nINTRODUCTION  \nLung cancer is one of the most common cancers and the leading cause of cancer-related deaths worldwide [1] with an estimated 2 million new cases and 1.76 million deaths annually. There are two main histologic types of lung cancer, with non-small cell lung cancer (NSCLC) patients accounting for 85% of all lung cancer patients and small cell lung cancer patients accounting for 15% . The 5-year survival rate for NSCLC patients is ~19%[2] . More than 50% of lung cancer patients have a low survival rate due to the fact that at the time of diagnosis many NSCLC patients present with metastatic disease. Thus, early diagnosis of the disease is critical to ensure that each patient receives the most effective treatment [3, 4] .  \nZinc ﬁnger CCCH-type containing 15 (ZC3H15), a member of the CCCH zinc ﬁnger family of proteins, is a highly conserved eukaryotic protein involved in various cellular processes associated with tumorigenesis [5] . The ZC3H15 gene, also known as LEREPO4 or DFRP1, is located on chromosome 2q32.1, and regulates developmentally-regulated GTP binding protein 1 (DRG1), which plays an important role in cellular signaling [6, 7] . In addition to the CCCH zinc ﬁnger domain, ZC3H15 also contains  \na conserved DRG family regulatory protein (DFRP) domain, which is required for the association of DFRP1/DFRP2 with DRG. DFRP proteins have been shown to stabilize the expression of their corresponding DRG proteins, as well as stabilize GTPases [8] . DFRP1 reportedly stimulates the GTPase activity of DRG1 by increasing its afﬁnity for potassium ions [9] . In addition, the binding of DFRP1 to DRG1 prevents DRG1 degradation, most likely via ubiquitination and proteasomal degr","cbCaifMlEWJKcxnA","https://ap.wps.com/l/cbCaifMlEWJKcxnA","pdf",5993273,15,"English","# Introduction\n## Molecular background of ZC3H15\n## Rationale for investigating ZC3H15 in NSCLC\n# Results\n## ZC3H15 role in NSCLC progression","[{\"question\":\"How was ZC3H15 identified as relevant to NSCLC?\",\"answer\":\"The study integrated transcriptome data from GEO and TCGA and used bioinformatics to screen key differentially expressed genes, identifying ZC3H15 as significantly increased in NSCLC tissue.\"},{\"question\":\"What molecular mechanism links ZC3H15 to PTEN and tumor progression?\",\"answer\":\"ZC3H15 binds PTEN via its DFRP structural domain and recruits the E3 ligase TRIM56, promoting PTEN ubiquitination and reducing PTEN expression.\"},{\"question\":\"How does ZC3H15 affect chemotherapy sensitivity and signaling pathways?\",\"answer\":\"Overexpression of ZC3H15 activates AKT-mTOR signaling, increases NSCLC proliferation, migration, and invasion, and enhances resistance to cisplatin.\"}]","ZC3H15 regulates the ubiquitination of PTEN via recruitment of TRIM56 and promotes malignant progression of non-small cell lung cancer | PDF",1790098560,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0f6b72c524a1fb47ef099730ff74f23.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/585e2d1746d4b102748ac674104f2f90.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3ff2fdad8dd1fa06672ecc93bd04fe4.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/85bf01f76e71e5a97067b8fd1aa55353.webp",980,1301]